Modest uptick projected in US health care spending growth rate in 2015

25 June 2014

After a five-year contraction in employer health care spending growth, medical inflation in the USA is projected to rise to 6.8% t in 2015, according to PricewaterhouseCooper’s (PwC) Health Research Institute (HRI).

In its annual report, Medical Cost Trend: Behind the Numbers, HRI projects that the stronger economy is now reaching the health sector, releasing a pent-up demand for care and services. Despite some higher utilization and the cost of expensive new cures, the higher expected growth rate in 2015 is modest compared to the double-digit annual increases seen throughout the late 1990s and early 2000s. However, the fact that health spending continues to outpace Gross Domestic Product (GDP) underscores the need for a renewed focus on productivity, efficiency and ultimately delivering better value for health care customers, the report states.

Confident consumers are spending more freely on health care due to the improved economy as well as increasing numbers of newly-insured, and HRI expects that trend to continue through next year. In addition, the high costs of specialty drugs will increase the health care spending growth rate, according to HRI.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical